You can read the original op-ed published in STAT News here. With the new Congress mostly in place, now split between a Democratic House and a Republican Senate, a new dynamic is in place. Any legislation, including efforts to rein in drug prices, will need to have bipartisan support to move forward. Bringing pricing restraint […]
This letter was originally sent to the office of Seema Verma on October 16, 2018. NCHC expressed its support for many aspects of the rule, but also shared some concerns.
National Coalition on Health Care Releases Major Report on Health Care Affordability WASHINGTON, DC – At a July 10th Capitol Hill event, the National Coalition on Health Care, an alliance of leading health care provider, purchaser, payer and consumer organizations, released a new report, Strategies for Improving the Affordability of High-Quality Health Care and Coverage. The report explores the […]
Statement by NCHC President and CEO John Rother on President Trump’s plan to address rising prescription drug prices “The National Coalition on Health Care has focused on rising drug costs as a key driver of unsustainable increases in the cost of healthcare for American consumers, employers, and taxpayers. The President today embraced some important, constructive […]
This op-ed was co-authored by NCHC’s President and CEO John Rother as well as Glen Stream. It was originally published by Medical Economics